Revenue (Quarterly) Chart

View Revenue (Quarterly) for STVN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 351.14M
March 31, 2026 320.06M
December 31, 2025 403.30M
September 30, 2025 354.29M
June 30, 2025 317.41M
March 31, 2025 270.06M
December 31, 2024 352.65M
September 30, 2024 305.25M
June 30, 2024 279.45M
March 31, 2024 256.14M
December 31, 2023 344.82M
September 30, 2023 295.26M
June 30, 2023 277.86M
Date Value
March 31, 2023 255.35M
December 31, 2022 297.96M
September 30, 2022 246.91M
June 30, 2022 249.30M
March 31, 2022 237.91M
December 31, 2021 265.83M
September 30, 2021 252.88M
June 30, 2021 245.90M
March 31, 2021 232.28M
December 31, 2020
September 30, 2020 183.57M
June 30, 2020 178.20M
March 31, 2020 150.30M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 1.835B
Bio-Rad Laboratories, Inc. 651.00M
Bruker Corp. 838.50M
Danaher Corp. 6.265B
Harvard Bioscience, Inc. 22.73M